Endometrial Cancer Stage I
Showing 1 - 25 of >10,000
Endometrial Cancer Stage I, Endometrial Cancer Stage II Trial in France (ambulatory surgery, standard surgery)
Completed
- Endometrial Cancer Stage I
- Endometrial Cancer Stage II
- ambulatory surgery
- standard surgery
-
Clermont-Ferrand, France
- +8 more
Dec 10, 2022
Endometrial Cancer Trial in Houston (Paclitaxel, Carboplatin, Dostarlimab)
Not yet recruiting
- Endometrial Cancer
- Paclitaxel
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Apr 6, 2023
Endometrial Carcinoma, Obesity, EIN Trial in Boston (CONCURRENT LAPAROSCOPIC HYSTERECTOMY AND WEIGHT LOSS SURGERY-Referral)
Recruiting
- Endometrial Carcinoma
- +4 more
- CONCURRENT LAPAROSCOPIC HYSTERECTOMY AND WEIGHT LOSS SURGERY-Referral
-
Boston, Massachusetts
- +1 more
Aug 2, 2022
Endometrial Tumors, Endometrial Tumor Malignant, Endometrial Tumor Malignant Stage I Trial in Beijing (Indication-extended
Recruiting
- Endometrial Neoplasms
- +4 more
- Indication-extended Fertility-sparing Therapy
-
Beijing, Beijing, ChinaPeking University People's Hosoital
Jul 12, 2023
Stage I Uterine Corpus Cancer AJCC v8 Trial in Chicago (procedure, other, drug)
Recruiting
- Stage I Uterine Corpus Cancer AJCC v8
- Sentinel Lymph Node Mapping
- +4 more
-
Chicago, IllinoisNorthwestern University
Dec 12, 2022
Cancer Survivor, Endometrial Carcinoma, Stage I Uterine Corpus Cancer AJCC v7 Trial in Palo Alto, San Jose (Communication
Active, not recruiting
- Cancer Survivor
- +6 more
- Communication Intervention
- +5 more
-
Palo Alto, California
- +1 more
Oct 24, 2022
Endometrial Carcinoma Stage I, Atypical Endometrial Hyperplasia Trial (No intervention)
Not yet recruiting
- Endometrial Carcinoma Stage I
- Atypical Endometrial Hyperplasia
- No intervention
- (no location specified)
Dec 3, 2022
Endometrial Cancer Stage I Trial in Seoul (Metformin)
Recruiting
- Endometrial Cancer Stage I
-
Seoul, Korea, Republic ofSamsung Medical Center
Sep 22, 2021
Endometrial Cancer Stage I, Sentinel Lymph Node, Surgery Trial in Australia, Singapore (TH BSO with SNB Note: If participants
Recruiting
- Endometrial Cancer Stage I
- +2 more
- TH BSO with SNB Note: If participants (≤45 years of age) wish to retain their ovaries a BSO may be omitted.
- TH BSO without retroperitoneal node dissection Note: If participants (≤45 years of age) wish to retain their ovaries a BSO may be omitted.
-
Camperdown, New South Wales, Australia
- +12 more
Sep 7, 2022
Endometrial Cancer, Endometrial Tumors, Endometrial Adenocarcinoma Trial in Istra (Laparoscopic hysterectomy with sentinel lymph
Recruiting
- Endometrial Cancer
- +8 more
- Laparoscopic hysterectomy with sentinel lymph node biopsy
-
Istra, Moscow Region, Russian FederationDepartment of Gynecologic Oncology, Moscow City Oncology Hospita
Oct 8, 2021
Endometrial Cancer Who Receive Standard Treatment for Their
Recruiting
- Endometrial Cancer
- +2 more
- Physical exam
-
Hartford, Connecticut
- +19 more
Jan 19, 2023
Endometrial Cancer Trial in Seoul (Sentinel lymph node mapping, Routine lymph node dissection)
Recruiting
- Endometrial Cancer
- Sentinel lymph node mapping
- Routine lymph node dissection
-
Seoul, Korea, Republic ofAsan Medical Center
Feb 18, 2022
Obesity, Endometrial Carcinoma Trial in Columbus (Gentle yoga therapy, counseling intervention, educational intervention)
Active, not recruiting
- Obesity
- Endometrial Carcinoma
- Gentle yoga therapy
- +4 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Jun 3, 2022
Among Reproductive Age Gynecological and Breast Cancer
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +29 more
- Healthcare Activity
- Survey Administration
-
Houston, TexasM D Anderson Cancer Center
Nov 2, 2022
Stage IV Ovarian Cancer, Testis Cancer, Refractory, Endometrial Cancer Recurrent Trial in Guangzhou (Claudin6 targeting CAR-NK
Recruiting
- Stage IV Ovarian Cancer
- +3 more
- Claudin6 targeting CAR-NK cells
-
Guangzhou, Guangdong, ChinaThe Second Affiliated Hospital of Guangzhou Medical University
Jun 5, 2022
Endometrial Tumor Malignant Stage I Trial in Shanghai (Megestrol Acetate 160 MG Oral Tablet, Medroxyprogesterone Acetate 500 MG,
Recruiting
- Endometrial Neoplasm Malignant Stage I
- Megestrol Acetate 160 MG Oral Tablet
- +3 more
-
Shanghai, Shanghai, China, ChinaObstetrics and Gynecology Hospital, Fudan University
Mar 25, 2022
Using Sonazoid Diagnose Early Stage Endometrial Cancer
Recruiting
- Endometrial Carcinoma Stage I
- Perflubutane Microspheres for Injection
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Jul 3, 2021
Malignant Female Reproductive System Tumor, Recurrent Cervical Carcinoma, Recurrent Endometrial Carcinoma Trial in Houston
Recruiting
- Malignant Female Reproductive System Neoplasm
- +24 more
- Quality-of-Life Assessment
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 6, 2022
Endometrial Cancer Stage I, Endometrial Cancer Stage II Trial in Worldwide (Vaginal brachytherapy, External beam radiotherapy,
Recruiting
- Endometrial Cancer Stage I
- Endometrial Cancer Stage II
- Vaginal brachytherapy
- +2 more
-
Vienna, Austria
- +30 more
Aug 16, 2021
Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I Trial in Beijing (statins (oral atorvastatin calcium tablet
Recruiting
- Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
- statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day);
-
Beijing, Beijing, ChinaPeking University People's Hospital
Oct 22, 2023
Advanced Breast Carcinoma, Advanced Endometrial Carcinoma, Advanced Fallopian Tube Carcinoma Trial in Houston (biological, drug,
Recruiting
- Advanced Breast Carcinoma
- +73 more
- Atezolizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
May 5, 2022
Endometrial Cancer Treatment Development
Completed
- Endometrial Cancer Stage
-
Yunusemre, Mani̇sa, TurkeyManisa Celal Bayar University
Jun 13, 2023
Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I Trial in Peking (Medroxyprogesterone acetate + Atorvastatin)
Recruiting
- Atypical Endometrial Hyperplasia
- Endometrial Carcinoma Stage I
- Medroxyprogesterone acetate + Atorvastatin
-
Peking, Beijing, ChinaWang Jianliu
Dec 29, 2022
Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in
Recruiting
- Recurrent Endometrial Carcinoma
- +12 more
- Everolimus
- +2 more
-
Houston, Texas
- +1 more
Sep 22, 2022
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8
Recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +129 more
- Cyclophosphamide
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Apr 8, 2022